Zim Laboratories Limited

About Zim Laboratories Limited

Zim provides innovative drug delivery solutions targeting patient convenience and adherence. It uses proprietary technologies (modified release and taste masking), to develop and manufacture differentiated pharmaceutical products.  We offer oral solid dosage formulations and pre-formulations (PFI) covering tablets, capsules, dry syrups, pellets, granules and orally disintegrating strips (ODS). We offer:-A)  Site transfer/variation Tablets- Sustained Release, Oral Disintegrating, fast disintegrating  
Capsule- Modified release - Pellets, Pellets + powder  
B) Co-Development and Technology Transfer - for Sustained & Modified Release formulations including non-infringing approaches. (Also method development  and validations on contract basis). 
C) pilot level Cgmp batch Scale-Up and commercial level scale-up services.  
D) Pre-formulation products in Bulk
         Pellet - Modified release 
         Directly Compressib...

  • IN
  • 2015
    On CPhI since
Contact info

Products from Zim Laboratories Limited

  • Dimenhydrinate SR pellet/Capsule

    Product Dimenhydrinate SR pellet/Capsule

    Dimenhydrinate SR pellet/CapsulebrhrbrZim Laboratories Ltd. provides a wide range of pellet which includes dimenhydrinate. It belongs to anti-emetics category. Contact us for more information.
  • Duloxetine DR pellet/Capsules

    Product Duloxetine DR pellet/Capsules

    Duloxetine DR pellet/CapsulesbrhrbrZim Laboratories Ltd. provides a wide range of pellet which includes duloxetine. It belongs to anti-depressant/anti-psychotic/anti-convulsants category. Contact us for more information.
  • Esomeprazole EC Pellet 8.5%/22/5% / Capsules

    Product Esomeprazole EC Pellet 8.5%/22/5% / Capsules

    Esomeprazole EC Pellet 8.5%/22/5% / CapsulesbrhrbrZim Laboratories Ltd. provides a wide range of pellet which includes esomeprazole. It belongs to hyperacidity, ulcers category. Contact us for more information.

Zim Laboratories Limited Resources

  • News ZIM Announces Submission of Marketing Authorization Application for 'Rizatriptan' orally dissolving film in Europe

    ZIM Laboratories Limited (ZIM) announced that it has filed the regulatory dossier for approval of Rizatriptan orally dissolving film in Europe.Rizatriptan orally dissolving film is a product developed using our Thinoral® technology which yields instantly wettable, rapidly dissolving, and stable films. The product is used in the treatment of migraine which is invariably associated with symptoms like nausea and vomiting.The fast dissolving features provides fast onset of action.